VIM and cancer: The upregulation of MMPs (MMP2, MMP9, and MMP13) was also reported in cancers overexpressing IL-32 along with other EMT markers including vimentin, Slug, Snail, and ZEB1, as well as they are well known for their contribution to cancer metastatic.